• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复合型小细胞肺癌:不同形态学成分的基因型和免疫表型分析

Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.

作者信息

Wagner Patrick L, Kitabayashi Naoki, Chen Yao-Tseng, Saqi Anjali

机构信息

Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, NY, USA.

出版信息

Am J Clin Pathol. 2009 Mar;131(3):376-82. doi: 10.1309/AJCPYNPFL56POZQY.

DOI:10.1309/AJCPYNPFL56POZQY
PMID:19228643
Abstract

Combined small cell lung carcinomas (CSCLCs) are small cell lung carcinomas (SCLCs) containing discrete areas of non-small cell morphologic components, found in up to 30% of SCLCs. We assessed immunophenotypic and genotypic similarity between the distinct morphologic constituents in 7 CSCLCs. Each was stained for synaptophysin, CD56, chromogranin, bcl-2, thyroid transcription factor (TTF)-1, cytokeratin 7, and PAX-5. Loss of heterozygosity (LOH) analysis was performed using markers on 3p (2 loci), 17p (3 loci), 17q (1 locus), and 22q (2 loci). The distinct components shared an identical immunophenotype in 6 cases; all were positive for synaptophysin and CD56 in both components. LOH analysis revealed shared loss of least 1 marker in every lesion, including LOH at 22q13 (characteristic of SCLC) in 5 tumors. The individual elements constituting CSCLCs are closely related in most cases despite their distinct morphologic appearances. The prevalent expression of synaptophysin and CD56 and loss of 22q13 suggest that these tumors are biologically closer to SCLC.

摘要

复合性小细胞肺癌(CSCLCs)是指包含非小细胞形态学成分离散区域的小细胞肺癌(SCLCs),在高达30%的SCLCs中可发现。我们评估了7例CSCLCs中不同形态学成分之间的免疫表型和基因相似性。每例均进行突触素、CD56、嗜铬粒蛋白、bcl-2、甲状腺转录因子(TTF)-1、细胞角蛋白7和PAX-5染色。使用位于3p(2个位点)、17p(3个位点)、17q(1个位点)和22q(2个位点)的标记进行杂合性缺失(LOH)分析。6例中不同成分具有相同的免疫表型;两个成分中突触素和CD56均呈阳性。LOH分析显示每个病变中至少有1个标记存在共同缺失,包括5例肿瘤中22q13(SCLC的特征性缺失)的LOH。构成CSCLCs的各个成分在大多数情况下尽管形态不同但密切相关。突触素和CD56的普遍表达以及22q13的缺失表明这些肿瘤在生物学上更接近SCLC。

相似文献

1
Combined small cell lung carcinomas: genotypic and immunophenotypic analysis of the separate morphologic components.复合型小细胞肺癌:不同形态学成分的基因型和免疫表型分析
Am J Clin Pathol. 2009 Mar;131(3):376-82. doi: 10.1309/AJCPYNPFL56POZQY.
2
Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.肺大细胞神经内分泌癌和小细胞肺癌中杂合性缺失的特征
Pathol Int. 2006 Aug;56(8):434-9. doi: 10.1111/j.1440-1827.2006.01985.x.
3
Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.TdT 在 Merkel 细胞癌和小细胞肺癌中的表达。
Am J Clin Pathol. 2011 Jun;135(6):831-8. doi: 10.1309/AJCPLCB2Q9QXDZAA.
4
Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.默克尔细胞癌与肺小细胞癌的免疫组化鉴别
Am J Dermatopathol. 2006 Apr;28(2):99-104. doi: 10.1097/01.dad.0000183701.67366.c7.
5
TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.TTF-1、细胞角蛋白7、34βE12和CD56/NCAM免疫染色在肺大细胞癌亚分类中的应用
Am J Clin Pathol. 2004 Dec;122(6):884-93.
6
Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Anticancer Res. 2004 Nov-Dec;24(6):4259-63.
7
Small cell lung carcinoma with marked bronchial epithelial involvement.小细胞肺癌伴显著支气管上皮受累。
Int J Surg Pathol. 2011 Aug;19(4):538-43. doi: 10.1177/1066896911408722. Epub 2011 Jun 1.
8
Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.定义小细胞肺癌和非小细胞肺癌合并症的基因组改变边界。
J Thorac Oncol. 2009 Feb;4(2):227-39. doi: 10.1097/JTO.0b013e3181952678.
9
Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.定量Ki-67增殖指数与CD56联合应用在小细胞肺癌及其他肺神经内分泌肿瘤细胞学诊断中的价值
Acta Cytol. 2013;57(3):281-90. doi: 10.1159/000346394. Epub 2013 Apr 25.
10
Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.组氨酸脱羧酶表达作为小细胞肺癌一种新的敏感且特异的标志物。
Mod Pathol. 2003 Jan;16(1):72-8. doi: 10.1097/01.MP.0000044485.14910.3A.

引用本文的文献

1
Clinical features and prognostic factors of IV combined small cell lung cancer: A propensity score matching analysis.IV 期小细胞肺癌的临床特征和预后因素:倾向评分匹配分析。
PLoS One. 2024 Nov 8;19(11):e0313221. doi: 10.1371/journal.pone.0313221. eCollection 2024.
2
The therapeutic effect of DX2 inhibition in nicotine-induced lung cancer progression.DX2抑制对尼古丁诱导的肺癌进展的治疗作用。
Mol Ther Oncol. 2024 Sep 10;32(4):200875. doi: 10.1016/j.omton.2024.200875. eCollection 2024 Dec 19.
3
The expression of YAP1 and other transcription factors contributes to lineage plasticity in combined small cell lung carcinoma.
YAP1及其他转录因子的表达有助于复合型小细胞肺癌的谱系可塑性。
J Pathol Clin Res. 2024 Sep;10(5):e70001. doi: 10.1002/2056-4538.70001.
4
Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study.探索不同组织学类型的小细胞肺癌治疗策略差异及局限期小细胞肺癌预后因素的预后影响:一项基于监测、流行病学和最终结果(SEER)数据库人群的研究
Heliyon. 2024 Jun 19;10(12):e32907. doi: 10.1016/j.heliyon.2024.e32907. eCollection 2024 Jun 30.
5
Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.通过显微解剖对小细胞肺癌进行基因组和转录组分析:揭示混合亚型的转化途径。
J Transl Med. 2024 Feb 21;22(1):189. doi: 10.1186/s12967-024-04968-4.
6
Combined small cell lung cancer: current progress and unmet needs.小细胞肺癌合并症:当前进展与未满足的需求
Am J Cancer Res. 2023 Sep 15;13(9):3864-3874. eCollection 2023.
7
Patient-derived spheroids and patient-derived organoids simulate evolutions of lung cancer.患者来源的球体和患者来源的类器官模拟肺癌的演变。
Heliyon. 2023 Feb 18;9(3):e13829. doi: 10.1016/j.heliyon.2023.e13829. eCollection 2023 Mar.
8
Whole-Process Treatment of Combined Small Cell Lung Cancer Initially Diagnosed as "Lung Squamous Cell Carcinoma": A Case Report and Review of the Literature.小细胞肺癌初始误诊为“肺鳞癌”的全程化治疗:1 例病例报告并文献复习。
Front Immunol. 2022 Mar 2;13:831698. doi: 10.3389/fimmu.2022.831698. eCollection 2022.
9
Case Report: Combined Small Cell Lung Carcinoma With Pulmonary Adenocarcinoma.病例报告:小细胞肺癌合并肺腺癌
Front Surg. 2022 Feb 4;9:830849. doi: 10.3389/fsurg.2022.830849. eCollection 2022.
10
In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.联合和共主要肺大细胞神经内分泌癌与腺癌的深入分子分析。
Int J Cancer. 2022 Mar 1;150(5):802-815. doi: 10.1002/ijc.33853. Epub 2021 Nov 10.